chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt recvd 1st dose of Hep B vax on 6FEB91 & on 8FEB91 pt devel severe vascular h/a & saw flashing lights; MD felt sx were related to vax; pt given Motrin; pt continues to have visual flashing lights, vertigo;
This spontaneous case from was retrieved on 02-May-2022 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2238063-1), reported by other non-healthcare professional (consumer) and concerned a 47-year-old, male patient.   The patient had no relevant medical history and was not taking any concomitant medications.  On 23-Nov-2021, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose: reported as one, route of administration: injection (SYR), anatomical location: right arm and indication:not reported). The batch number reported was 308433.  On the same day, the patient was vaccinated with non-company, co-suspect Pfizer BioNTech COVID-19 vaccine (tozinameran; dose: reported as three, route of administration: injection (SYR), anatomical location: left arm and indication: not reported). The batch number reported was FJ1620.  On an unspecified date, reported as around December, an unknown amount of time after receiving Flucelvax Quadrivalent and Pfizer BioNTech COVID-19 vaccine, the patient noticed tinnitus in both ears got louder, with ringing louder than it used to be.   On 11-Jan-2022, the patient went to audiologist, where the acoustic stimulation tests were performed and resulted in no identified issues, results of hearing test were normal.  At the time of initial reporting, the patient had not recovered from the event 'tinnitus'.  The reporter did not provide a causality assessment. The reporter was not sure that it was a result of the vaccine, but after reading an article on this possibility, thought to report this.   The case was assessed as non-serious.  Company comment: A 47-year-old male patient developed tinnitus after receiving Flucelvax Quadrivalent and non-company co-suspect Pfizer BioNTech COVID-19 vaccines. The acoustic stimulation tests and hearing test were normal. Elapsed time between vaccinations and the onset of the event is unknown. Due to lack of information, causality is unassessable. Sender's Comments: A 47-year-old male patient developed tinnitus after receiving Flucelvax Quadrivalent and non-company co-suspect Pfizer BioNTech COVID-19 vaccines. The acoustic stimulation tests and hearing test were normal. Elapsed time between vaccinations and the onset of the event is unknown. Due to lack of information, causality is unassessable.
Headache, Rash, fatigue, right arm soreness, right arm rash 1 week later Narrative:
Child refused to walk for 5 days, complained of leg pain, one worse than other, mother dose not recall which. Provider not made aware until next.
After 12 hours had a headache for 15 hours.  On day 2, developed nasal congestion, sore throat, dry cough, phlegm, loss of smell & taste, feels like fluid in lungs.
Generalized malaise, fatigue, and dizziness that has progressively worsened. She did take the "high dose" flu shot late last week and has felt "horrible" since then.
SYMPTOMS STARTED AROUND 3 HOURS AFTER VACCINATION AND LASTED FOR 5 HOURS: - HEADACHE -CHEST TIGHTNESS (CONSTRICTED BREATHING)- MALAISE- FEELING OF BEING COLD THE ENTIRE DAY.
patient received 2nd dose moderna vaccine 28 days after 1st dose  after 20 mins patient reported feeling dizzy and nauseous.  pharmacist tried cold compress and breathing in a bag however patient continued to feel extremely dizzy and nauseous.  EMS responded checked patient's blood sugar started an IV and administered zofran for the nausea.  they took patient to hospital for evaluation
pt vaxed 25FEB92 & on 27FEB pt had an inject site reaction consisting of redness, swelling, induration & vesiculation which was 4" in diameter; tx included topical cortisone; sx resolved w/in 48 hrs;
Lots FAV074 and FAV097 as well as an unknown lot in 2007 have other shots. Cant exactly remember when the pain symptoms started. I can't remember things from last month much less that many years ago. My wife is pushing me to report my problems because it has become a very serious issue with my health.
In April 2022, he started noticing he had a itchy rash around his right ribcage area with pustules that looked like shingles. The rash spread to both forearms and shins as well as his back. No pain noted. On May 5, 2022 I took him to the dermatologist who stated it looked like an allergy and that it was not shingles. He took a scraping of the sores and sent it off for testing. The doctor told Dad to stop all the medications that he was on and they prescribed prednisone and triamcinolone cream. The prednisone caused bloody stool but the dermatologist stated to continue using it. On May 19th, we went back to the doctor for results and they said the results of test showed it to be some kind of allergy. He said to continue the triamcinolone cream and to take Zyrtec daily. On 6-16, he went back to the same doctor facility but saw a different doctor for a follow-up and they stated we could cut down on the number of times of application of the cream. The rash came back with a vengeance on his shins and we went in to the doctor on 6-22 and was given Clobetasol Eropiomate cream to his legs and to continue the triamcinolone to his upper body only. Dad went to his primary care physicians office on 8-2 and had bloodwork and a cologuard test and all came back normal except Vitamin D. He also had an appointment and went in to the doctor on 8-18 and he was put back on the prednisone and to continue both creams. He also was told to remain off of the supplements and to take the Zyrtec twice daily. He has a follow-up appointment for 10-6-2022.
Pt attended a drive through vaccination clinic. About 15 minutes after the vaccine was given the pt notified staff that her tongue was swelling.  The medical provider went to her vehicle, pt was found alert and in no acute distress. Pts tongue was edematous with about a 30% increase in size beyond baseline.  Pt was given a single dose of epinephrine 0.3mg IM in her right thigh. Pt was escorted into the clinic. BP 166/98 HR 86 RR18 SpO2 99%RA. Pt was given Solumedrol 60mg IM and diphenhydramine 50mg PO.  Pt complained of itchy skin. No skin rashes visible.  Pt was monitored. Tongue swelling resolved, no other complaints.  At 1630 VSS and PE was normal Pt was discharged home by personal vehicle driven by patients friend. Pt given  strict ER precautions.
SHORTNESS OF BREATH; EARLY MENSTRUAL PERIOD; DIARRHEA; LETHARGY; WEAKNESS; NAUSEA; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included stroke, and concurrent conditions included low iron, egg allergy, and pork allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Concomitant medications included iron for low iron. On an unspecified date, the subject experienced shortness of breath, early menstrual period, diarrhea, lethargy, weakness, nausea, and injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nausea, diarrhea, weakness, lethargy, shortness of breath, early menstrual period and injection site pain was not reported. This report was non-serious.; Sender's Comments: v0-Medical assessment comment not required according to standard operating procedures.
Information has been received from a registered concerning an 84 year old white male with no illness at the time of vaccination, drug reactions/allergies or pertinent medical history who on 17-DEC-2007 at 18:05 PM was vaccinated with a dose pneumococcal 23v polysaccharide vaccine (lot# 659148/1382U) IM in the left arm. There was no concomitant medication. On 18-DEC-2007 at 12:00 o'clock (AM or PM not specified) the patient developed an induration, heat, surrounding redness at the injection site, dependent swelling beneath the elbow and significant pain noted at both areas. The duration was four days. On 21-DEC-2007, the patient recovered. Additional information is not expected.
Information has been received from a Registered Nurse concerning to multiple unspecified patients (ages and genders not reported) who on unknown dates were vaccinated with an improperly stored doses of RECOMBIVAX HB (Lot No. L044694, exp. not reported), 5 microgram (route not reported). The doses were part of an excursion with temperature of 35F for 1 hour. There was no previous temperature excursion. The reporter did not know if any adverse effect were reported. This is one of several report from the same source. Additional information has been requested.
7 days p/vax lt deltoid area became red & inflamed approx 6" in diameter around inj site;2 hardened areas appeared below inj site which were approx 4cm in diameter;rash appeared on arm from inj site down to hardened areas;poss allerg react
23 y/o female who had intimate contact with primary vaccinee (vaccination date of 2/22/12) on 2/26, 2/29, 3/3 and 3/8. During at least one of these encounters the vaccination site dressing came dislodged/off. On 3/11/12 she developed fever, body aches, and vaginal pruritis. On 3/12/12 the pt developed itchy lesions of her thigh and vulva. The pt scratched all of lesions and irritated areas. Additionally, she applied TEMOVATE cream to her vaginal area. She developed a lesion on her back on 3/13/12. Lesion to thigh and vulva tested positive for orthopox virus (per LRN) 3/15/12. Pt used tampons to manage menses 3/12-3/15. Pt was treated with VIG on 3/17/12. Symptoms: Dysuria, Disturbance of skin sensation.
4:45pm nausea, acute fatigue, headache  5:55pm vomiting x2, low fever, chills x 3.5 hours 9:25pm fatigue and flu-like aches only, acute symptoms lessening
The day after the vaccination occurred, the patient had moderate-severe pain when lifting her arm overhead or lifting heavy objects. The pain comes and goes throughout the day, and disrupts her sleep at night. There months later the pain is finally better.
sore shoulder; lethargy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received BNT162b2 (BNT162B2), on 02Mar2021 as dose 1, single (Lot number: EN6202) at the age of 67 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "sore shoulder"; LETHARGY (non-serious), outcome "unknown".  Additional information: It was reported that patient had contracted COVID 3 mos after his 5th dose (Bivalent). He rarely had even mild reactions (sore shoulder; a day of lethargy) after each dose.
Patient got the ZOSTAVAX on Sunday at the pharmacy. On Tuesday patient felt very fatigue, diminished appetite and has a slight headache. The site itself is tender and red. Patient said she had a flushed face, watery eyes, and tenderness at the site on Monday.
No adverse event.  Vaccine error.  First dose given was expired 4/27/21.  Caught right away.  Dose of unexpired Vaccine given same visit.
itchy injection site; swollen injection site; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy injection site), VACCINATION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (injection site redness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included PANTOPRAZOLE and SUCRALFATE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (injection site redness). On 21-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy injection site), VACCINATION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Patient was reported to use ice pack for the reported events.
10:54 Throat thick, report feeling "funny"/ strange. BP 110/60  10:57 EPI administered, BP 110/80 Throat feels better. Shaky. 11:02 Transported
First shot 5-2021 Second shot 6-2021. Booster shot 12-2021. March 2022 I woke up one morning, out of the blue, I was dizzy. Thought just because I go up too fast. But it continued to be mild all day and for days after. Saw  PCP and they said  I have vertigo. It can come suddenly. Put me on medication. It did help. April 2022 is when the ringing started in both my ears with mild to some sharp pain headaches daily.  I went to ENT, (June) 2021 had hearing test (passed) , checked in ears (no infections) ordered MRI(august) (nothing found). Referred to Neurologist(October) for the headache and they could not help. My symptoms were not something for their specialty. Mean time went to Chiropractor thinking crystals or neck out. (nothing) ENT then said, that is all he can do for me. And an Audiologists could only help if I had hearing loss. Dates may not be completely accurate but I can get full records if needed.
Left thigh with 7 X 4 cm redness superficial with marked swelling and induration of thigh approx. 10 X 12cm; noted approx. 18 hours, post vax. Treated with Benadryl and Motrin.
Swelling at injection site which migrated distally with more redness, swelling, and heat at migratory site.
Very red and swollen at injection site, hurts and also itches. Upset stomach, gas, stomach pain, muscle pain in sides and back, general body ache, headache, and feeling very tired
Left arm pain, fever, redness at site. Dx Cellulitis- Tx Augmentin 500mg   BID 7 days
Rash developed at injection site 16 days after injection. Not painful. Have not sought treatment.
mom reports that the noc a/seen in office, the pt woke mom up when gasping noise was heard;the baby was reported as limp & sleeping & when patted on back not felt to be breathing;got further stimulation & since has been nl;
Severe fatigue, chills, beginning on 1/31/2021, stuffy nose, vomiting, low BP and high heart rate
Low grade fever, extreme fatigue, body aches, joint aches, headache began 2/14/2021 morning & ended 02/15/2021 at about 9:00  pm Covid arm--large area on left upper arm that is red, swollen, warm, itchy. It is still bad now on 2/16/2021 at 8:30 pm. I did take a photo
Breakthrough case. Had dose 4 in 04/2022, the tested positive for COVID-19 on 06/28/2022. Took Home test and tested Positive. Called Dr for a Telemedicine appt, and was prescribed Paxlovid, but didn't want to take it if I didn't have to. and decided not to take it. Finally tested negative 07/18/2022.
ACUTE STEMI HEART ATTACK  -  VENTRICULAR FIBRILLATION  -   99.9% BLOOD CLOT IN RIGHT CORONARY ARTERY
Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment medication provided. no concomitant medication provided. The patient gave consent for safety team to contact him but not his health care provider. Patient was unable to provide information on lot and expiration date. The patient showed concerned about getting the second dose of Moderna COVID-19 vaccine second dose was scheduled on 04Apr2021.
Onset of B type symptoms within 3-4 days following vaccination. Robust take noted. Progressed to generalized papular lesions on face, head, chest, back, bilateral upper and lower extremities.
Severe headaches that had seizure-like component; syncope episodes;  visual disturbances; difficulty concentrating; fatigue.  Continues to struggle with chronic headaches.
(L) thigh with redness, 2 cm induration. (Local reaction) - BENADRYL given.
Developed herpetic rash on left ear on February 27, 2021 and then developed a left facial nerve paralysis on March 10, 2021
ended up meningitis scariest; autism type 2; This case was reported by a consumer via interactive digital media and described the occurrence of meningitis in a infant female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, couple of days after receiving Bexsero, the patient experienced meningitis (serious criteria GSK medically significant) and autism (serious criteria GSK medically significant). On an unknown date, the outcome of the meningitis and autism were unknown.   The reporter considered the meningitis and autism to be related to Bexsero.  Additional information was provided as follows: The patient had the shot and a few day later ended up with meningitis scariest thing ever had to go though. The patient was a healthy child and was developing normal like her twin brother. The mother of patient noticed after patient got better that something was different about her. The patient was tested and found out she was type 2 autism. The mother of the patient wander if it was due to the shot. The situation of patient was hard as parent to see, she believed that it was a side effect to the vaccination which triggered her to get meningitis from the shot and she believed that meningitis was the huge link to autism.
Fatigue for 2 months.  Quarter size blisters on arms and legs for 2 months.
Pfizer Covid-19 vaccine (5yrs-11yrs) given to 13 yr old instead of Comirnaty Covid vaccine (12+ yrs). Reported event to Pfizer, was told to repeat vaccination 8 weeks from last dose to ensure full immunity.
Information has been received from a healthcare worker (purchasing manager) via company representative, and registered nurse regarding an unspecified number of patients of an unknown age and gender. On an unknown date, the patients were vaccinated with ROTATEQ (dose and rout were not provided) (lot # J009725, expiration date 04-MAR-2015) and PEDVAXHIB (dose and route were not provided) (Lot number reported as J010385, expiration date 28-MAY-2016). The registered nurse confirmed that unspecified patients experienced unspecified adverse effects after receiving ROTATEQ and PEDVAXHIB. At the time of the report, the patients outcome was unknown. Additional information has been requested.
I took the Gardasil 9 vaccine september 3rd, and 6 days later i started suffering headaches and dizziness also on the night of september 11th i suffered from muscle tightness and numbness at the same time plus weakness i ended up at the emergency room it is now the night of september 16 and the headache is still going on its been a week now of headaches and im really worried now and some answers if this is normal or will it go away. I also want to add i had never suffered any migraine problem for a complete week till now wich is why I'm really worried. Thanks
SHORT OF BREATH; DIZZY; FEELING EXTREMELY SICK; FATIGUED; A HEADACHE; FEELING WEAK RIGHT AFTER VACCINATION; This spontaneous report received from a patient concerned a 37 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid, and concurrent conditions included non alcoholic, and non smoker, and other pre-existing medical conditions included the patient had no known allergies, no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-MAR-2021, Laboratory data included: COVID-19 virus test (NR: not provided) Negative. On 23-MAR-2021, the subject experienced feeling weak right after vaccination. On 25-MAR-2021, the subject experienced short of breath. On 25-MAR-2021, the subject experienced dizzy. On 25-MAR-2021, the subject experienced feeling extremely sick. On 25-MAR-2021, the subject experienced fatigued. On 25-MAR-2021, the subject experienced a headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling weak right after vaccination, feeling extremely sick, fatigued, dizzy, a headache, and short of breath. This report was non-serious.
This case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 71-year-old male patient who received SHINGRIX (batch number P57AA, expiry date 20th March 2020) for prophylaxis. On 5th March 2019, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In March 2019, less than a week after receiving SHINGRIX, the patient experienced swelling arm, erythema of extremities and pain in arm. On an unknown date, the outcome of the swelling arm, erythema of extremities and pain in arm were not recovered/not resolved. It was unknown if the reporter considered the swelling arm, erythema of extremities and pain in arm to be related to SHINGRIX. Additional case details were reported as follows: The age at vaccination was not reported. The patient was vaccinated with SHINGRIX and experienced redness on his arm, swelling the size of a grapefruit, and pain. The exact start date were not provided, the patient stated yesterday it was kind of small and then today it got bigger, the size of a grapefruit. The pain was a little worse, but then got better on the day of reporting. The patient had not provided the further specifics information to the reporter.
I got the Modern booster shot on February 18, 2022. On the morning of February 28, 2022, I woke up with severe itching under my bra line. In the following days, I experienced uncontrollable itching and dermatographia - what I characterized at the time as hives or welts. Every time I would scratch my skin, and sometimes even when I didn't, big red welts would appear.  They would go away soon after they appeared and tended to migrate all over my body, including stomach, back, neck, chest, legs, arms, face, forehead, and ears.  The same morning I noticed the itching, I also had really, really severe heartburn - like I'd swallowed a pill that was stuck in my throat and acid was coming up to meet it. It's now May, and even though my symptoms have abated somewhat, I'm still dealing with this. I take Claritin and Pepcid daily and have received two steroid shots.
Received first dose of COVID vaccine @ 2:08 pm, complained of dizziness, nausea, abdominal pain, sweatiness @ 2:13pm.  Placed in zero-gravity chair prior to vaccine due to anxiety with needles.  Vital signs assessed, denies shortness of breath.  At 2:33 pm, water is given to drink as client reports "abdominal pain is better, nausea going away, no longer sweating."  At 2:43 pm, client reports symptoms have resolved, made aware to follow up with primary care.  Client leaves observation area, walking with steady gait, at 2:50 pm.